Psoriatic Resolved Skin Epidermal Keratinocytes Retain Disease-Residual Transcriptomic and Epigenomic Profiles

The disease-residual transcriptomic profile (DRTP) within psoriatic healed/resolved skin and epidermal tissue-resident memory T (TRM) cells have been proposed to be crucial for the recurrence of old lesions. However, it is unclear whether epidermal keratinocytes are involved in disease recurrence. There is increasing evidence regarding the importance of epigenetic mechanisms in the pathogenesis of psoriasis. Nonetheless, the epigenetic changes that contribute to the recurrence of psoriasis remain unknown. The aim of this study was to elucidate the role of keratinocytes in psoriasis relapse. The epigenetic marks 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) were visualized using immunofluorescence staining, and RNA sequencing was performed on paired never-lesional and resolved epidermal and dermal compartments of skin from psoriasis patients. We observed diminished 5-mC and 5-hmC amounts and decreased mRNA expression of the ten-eleven translocation (TET) 3 enzyme in the resolved epidermis. SAMHD1, C10orf99, and AKR1B10: the highly dysregulated genes in resolved epidermis are known to be associated with pathogenesis of psoriasis, and the DRTP was enriched in WNT, TNF, and mTOR signaling pathways. Our results suggest that epigenetic changes detected in epidermal keratinocytes of resolved skin may be responsible for the DRTP in the same regions. Thus, the DRTP of keratinocytes may contribute to site-specific local relapse.

[1]  E. Shen,et al.  Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review , 2022, Frontiers in Immunology.

[2]  M. Hoon,et al.  GPR15L is an epithelial inflammation-derived pruritogen , 2022, Science advances.

[3]  Marta Kowalczyk,et al.  Real‐world evidence on time to relapse of plaque psoriasis after discontinuation of biologic treatment in Poland , 2021, Dermatologic therapy.

[4]  L. Kemény,et al.  Stress-Related Regulation Is Abnormal in the Psoriatic Uninvolved Skin , 2021, Life.

[5]  C. Johansen,et al.  IL-37 Expression Is Downregulated in Lesional Psoriasis Skin , 2020, ImmunoHorizons.

[6]  M. Biermann,et al.  Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life , 2020, The Journal of dermatological treatment.

[7]  L. Kemény,et al.  Cartilage Oligomeric Matrix Protein Negatively Influences Keratinocyte Proliferation via α5β1-Integrin: Potential Relevance of Altered Cartilage Oligomeric Matrix Protein Expression in Psoriasis , 2020 .

[8]  L. Kemény,et al.  COMP negatively influences keratinocyte proliferation via α5β1-integrin: Potential relevance of altered COMP expression in psoriasis. , 2020, The Journal of investigative dermatology.

[9]  C. Patruno,et al.  A novel vehicle for the treatment of psoriasis , 2019, Dermatologic therapy.

[10]  C. Lian,et al.  Loss of the Epigenetic Mark, 5-hmC, in Psoriasis: Implications for Epidermal Stem Cell Dysregulation. , 2019, The Journal of investigative dermatology.

[11]  J. Voorhees,et al.  Psoriasis: Past, Present, and Future. , 2019, The Journal of investigative dermatology.

[12]  R. Schmid,et al.  Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab. , 2019, The Journal of allergy and clinical immunology.

[13]  Katherine Li,et al.  Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept. , 2019, The Journal of allergy and clinical immunology.

[14]  Xiaolu Yang,et al.  The lncRNA Neat1 promotes activation of inflammasomes in macrophages , 2019, Nature Communications.

[15]  M. Pichler,et al.  The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases , 2019, International journal of molecular sciences.

[16]  Ratnesh K Singh,et al.  Immunohistochemical Detection of 5-Methylcytosine and 5-Hydroxymethylcytosine in Developing and Postmitotic Mouse Retina , 2018, Journal of visualized experiments : JoVE.

[17]  Yunlu Gao,et al.  Combined Transcriptomic Analysis Revealed AKR1B10 Played an Important Role in Psoriasis through the Dysregulated Lipid Pathway and Overproliferation of Keratinocyte , 2017, BioMed research international.

[18]  Jeffrey A. Porter,et al.  A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia , 2017, Science Signaling.

[19]  E. Butcher,et al.  A Mucosal and Cutaneous Chemokine Ligand for the Lymphocyte Chemoattractant Receptor GPR15 , 2017, Front. Immunol..

[20]  H. Wee,et al.  SAMHD1 acetylation enhances its deoxynucleotide triphosphohydrolase activity and promotes cancer cell proliferation , 2017, Oncotarget.

[21]  P. Blackshear,et al.  Tristetraprolin expression by keratinocytes controls local and systemic inflammation. , 2017, JCI insight.

[22]  T. Rauen,et al.  DNA methylation in systemic lupus erythematosus. , 2017, Epigenomics.

[23]  B. Becher,et al.  IL-12 protects from psoriasiform skin inflammation , 2016, Nature Communications.

[24]  R. Fåhraeus,et al.  Epigenetic regulation of OAS2 shows disease-specific DNA methylation profiles at individual CpG sites , 2016, Scientific Reports.

[25]  A. Bayat,et al.  The Aldo-Keto Reductase AKR1B10 Is Up-Regulated in Keloid Epidermis, Implicating Retinoic Acid Pathway Dysregulation in the Pathogenesis of Keloid Disease. , 2016, The Journal of investigative dermatology.

[26]  Liangdan Sun,et al.  Epigenome-Wide Association Analysis Identified Nine Skin DNA Methylation Loci for Psoriasis. , 2016, The Journal of investigative dermatology.

[27]  Zheng Hu,et al.  Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment , 2016, Recent patents on anti-cancer drug discovery.

[28]  S. Arron,et al.  Landscape of Long Noncoding RNAs in Psoriatic and Healthy Skin. , 2016, The Journal of investigative dermatology.

[29]  V. Sumantran,et al.  Microarray Analysis of Differentially-Expressed Genes Encoding CYP450 and Phase II Drug Metabolizing Enzymes in Psoriasis and Melanoma , 2016, Pharmaceutics.

[30]  J. Bernstein,et al.  Multiple Transcriptome Data Analysis Reveals Biologically Relevant Atopic Dermatitis Signature Genes and Pathways , 2015, PloS one.

[31]  P. Gisondi,et al.  European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[32]  S. Arron,et al.  Antiviral gene expression in psoriasis , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[33]  Zhaoyuan Liu,et al.  Epigenetic Downregulation of SFRP4 Contributes to Epidermal Hyperplasia in Psoriasis , 2015, The Journal of Immunology.

[34]  A. Mutirangura,et al.  Patterns and functional roles of LINE-1 and Alu methylation in the keratinocyte from patients with psoriasis vulgaris , 2015, Journal of Human Genetics.

[35]  R. Fåhraeus,et al.  Correlation between Reversal of DNA Methylation and Clinical Symptoms in Psoriatic Epidermis Following Narrow-Band UVB Phototherapy , 2015, The Journal of investigative dermatology.

[36]  Na Luo,et al.  AP-57/C10orf99 is a new type of multifunctional antimicrobial peptide. , 2015, Biochemical and biophysical research communications.

[37]  A. Shevchenko,et al.  SAMHD1 prevents autoimmunity by maintaining genome stability , 2014, Annals of the rheumatic diseases.

[38]  J. Gribben,et al.  Loss of 5-hydroxymethylcytosine in cancer: cause or consequence? , 2014, Genomics.

[39]  E. Butcher,et al.  Orphan chemoattractant receptor GPR15 mediates dendritic epidermal T‐cell recruitment to the skin , 2014, European journal of immunology.

[40]  L. Kemény,et al.  Regulatory networks contributing to psoriasis susceptibility. , 2014, Acta dermato-venereologica.

[41]  Y. Wasfi,et al.  Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis. , 2014, The Journal of allergy and clinical immunology.

[42]  Guoqing Wang,et al.  Gene expression profile based classification models of psoriasis. , 2014, Genomics.

[43]  Daniel R. Caffrey,et al.  A Long Noncoding RNA Mediates Both Activation and Repression of Immune Response Genes , 2013, Science.

[44]  K. Ramana,et al.  Prevention of allergic rhinitis by aldose reductase inhibition in a murine model. , 2013, Inflammation & allergy drug targets.

[45]  Guangliang Yin,et al.  Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. , 2013, Journal of autoimmunity.

[46]  Abraham J. Khorasani,et al.  Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma , 2012, Cell.

[47]  Mayte Suárez-Fariñas,et al.  Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis , 2012, The Journal of investigative dermatology.

[48]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[49]  J. Farrés,et al.  Biological Role of Aldo–Keto Reductases in Retinoic Acid Biosynthesis and Signaling , 2012, Front. Pharmacol..

[50]  Alan Menter,et al.  A subset of methylated CpG sites differentiate psoriatic from normal skin , 2011, The Journal of investigative dermatology.

[51]  P. Thorner,et al.  Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation. , 2011, Human pathology.

[52]  Yi Zhang,et al.  Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. , 2011, Genes & development.

[53]  G. Ming,et al.  Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond , 2011, Cell cycle.

[54]  K. Ramana,et al.  Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. , 2011, Chemico-biological interactions.

[55]  K. Ramana,et al.  Aldose reductase inhibition suppresses airway inflammation. , 2011, Chemico-biological interactions.

[56]  M. Suárez-Fariñas,et al.  Resolved psoriasis lesions retain expression of a subset of disease-related genes. , 2011, The Journal of investigative dermatology.

[57]  Q. Lu,et al.  Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. , 2010, Journal of dermatological science.

[58]  Andrew Johnston,et al.  Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. , 2010, The Journal of investigative dermatology.

[59]  R. Gay,et al.  DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. , 2009, Arthritis and rheumatism.

[60]  Israel Steinfeld,et al.  BMC Bioinformatics BioMed Central , 2008 .

[61]  J. Gong,et al.  The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance , 2008, The British journal of dermatology.

[62]  Q. Lu,et al.  DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients. , 2008, Autoimmunity reviews.

[63]  Lisa C. Zaba,et al.  Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses , 2007, The Journal of experimental medicine.

[64]  L. Kemény,et al.  Human adult epidermal melanocytes cultured without chemical mitogens express the EGF receptor and respond to EGF , 2007, Archives of Dermatological Research.

[65]  Zohar Yakhini,et al.  Discovering Motifs in Ranked Lists of DNA Sequences , 2007, PLoS Comput. Biol..

[66]  K. Ramana,et al.  Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells. , 2006, Investigative ophthalmology & visual science.

[67]  A. Mutirangura,et al.  SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis , 2006, Journal of Molecular Medicine.

[68]  C. Griffiths,et al.  Psoriasis: epidemiology, clinical features, and quality of life , 2005, Annals of the rheumatic diseases.

[69]  K. Wittkowski,et al.  Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[70]  L. Kemény,et al.  Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin. , 2004, The Journal of investigative dermatology.

[71]  K. Ramana,et al.  Inhibition of aldose reductase attenuates TNF‐α‐induced expression of adhesion molecules in endothelial cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  J. Geiger.  Efficacy of acitretin in severe psoriasis. , 2003, Skin therapy letter.

[73]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[74]  Sheung Tat Fan,et al.  Identification and Characterization of a Novel Human Aldose Reductase-like Gene* , 1998, The Journal of Biological Chemistry.

[75]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[76]  J. Voorhees,et al.  Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. , 1995, The Journal of clinical investigation.

[77]  C. Ackerley,et al.  Myelin in multiple sclerosis is developmentally immature. , 1994, The Journal of clinical investigation.

[78]  G. Brady,et al.  The role of charge microheterogeneity of basic protein in the formation and maintenance of the multilayered structure of myelin: A possible role in multiple sclerosis , 1986, Journal of neuroscience research.